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Improving Breastfeeding Rates by Using Glucose Gel to Treat Newborn Hypoglycemia 
Clinical Leadership Theme 
 The Clinical Leadership theme that this project is associated with is clinical outcomes 
management, and the role is outcomes manager. The project’s team will be using the latest 
evidence and research to improve newborn hypoglycemia outcomes and achieve increased 
breastfeeding rates. The aim is to improve the current protocol for treatment of newborn 
hypoglycemia by transitioning from supplemental formula feedings to oral glucose gel. The 
change will take place in a large community hospital in Southern California on the Maternal-
Child Health units—Labor and Delivery, Mother/Baby, and NICU. The process begins with the 
bedside administration of oral dextrose gel to newborn infants experiencing hypoglycemia. The 
process ends with the infants’ blood glucose levels after initiation of treatment. 
 By working on the process, the project’s team expects to primarily increase breastfeeding 
rates. Secondary aspects that the team hopes to affect are (1) abiding by the hospital’s Baby- 
Friendly initiatives, (2) decreasing infant admission rates to the NICU for IV dextrose therapy, 
and (3) promoting maternal-child bonding. 
 This project is timely because of the identified need to (1) initiate a treatment that is more 
cost effective, (2) reduce maternal-infant separation, and (3) improve patient satisfaction. 
Statement of the Problem 
 Newborn hypoglycemia occurs in 5-15% of newborns during the postnatal period 
(Weston et al., 2016). Per hospital policy, newborns showing clinical signs of hypoglycemia or 
infants who have predisposing risk factors, get screened for hypoglycemia using a capillary heel-
lance blood sample. This unit’s specific target range is a blood glucose level greater than or 
equal to 40 mg/dL. Infants with numbers less than this receive supplemental infant formula and 
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in severe cases, closer monitoring or intravenous dextrose therapy, causing them to be 
transferred to the newborn nursery or NICU. Due to this, the hospital’s breastfeeding rates have 
dropped, in turn affecting patient satisfaction. This transfer of care also delays the initiation of 
breastfeeding, interferes with mother/baby bonding, and leads to increased costs.  
Project Overview 
 Through evidence based research, various literature reviews, and discussions with the 
Nurse Educator, oral/buccal dextrose gel was looked into as a form of treatment for infant 
hypoglycemia. With this intervention, the specific goal of the project is to increase the 
percentage of the hospital’s breastfeeding rates by 20%. This aim statement relates to the global 
aim statement because it supports the primary goal of increasing breastfeeding rates while 
supporting the secondary effects of increased maternal-infant bonding, decreased admission rates 
to the NICU, and improved abidance to the hospital’s Baby Friendly Initiative.  
Rationale 
 Assessing a microsystem involves gathering specific information surrounding a possible 
concern. Using that information can often lead to a data driven solution (Harris, Roussel, & 
Thomas, 2014). When assessing this microsystem, a need was identified to improve treatment for 
newborn hypoglycemia to potentially improve breastfeeding rates, and to better coincide with 
Baby-Friendly Hospital Initiatives.  
 In an audit of the monthly breastfeeding rates for 2016, on average the unit had a 65% 
rate across the year. In addition, these rates also caused decreased patient satisfaction scores 
because patients who wished to breastfeed were disappointed when their infants had to be 
removed from them to formula feed. In severe cases, infants must be admitted to the NICU for 
intravenous (IV) dextrose therapy.  
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 For the projected costs, the author will use the cost of her labor to the hospital as a 
Registered Nurse. As a current full-time employee, the hospital will spend an estimated $78,630 
in employment and benefits for individual labor costs for the 2017 fiscal year (Hospital X, 2017). 
Comparisons will be made between these costs, the projected goal of increasing breastfeeding 
rates to 85%, and the cost of newborn hypoglycemia treatment with oral glucose gel.  
 In 2016 there were 6,699 births at this hospital. Of those infants, 4,354 (65%) were 
breastfed, 66 had to be admitted to the NICU for IV dextrose therapy, and 2,095 were formula 
fed, either by choice or due to infant hypoglycemia. According to Rawat et al. (2016), the cost of 
newborn admission to the NICU for the treatment of hypoglycemia with IV dextrose therapy is 
$31,820 per case, and the cost of successful treatment with oral glucose gel is $5,037 per case. 
Therefore, in 2016, the unit spent a total $2.1 million on NICU admission costs. The cost of 
formula feeding infants over a hospital stay of three days is about $6.30 per infant. If the 
intervention of oral glucose gel causes a 20% increase in breastfeeding rates, assuming that is 
20% less infants formula feeding and maybe two less admissions to the NICU, then the hospital 
will save an estimated $2,649 on formula and $63,640 on NICU admission costs in the 2017 
year. 
 Clearly, the implementation of this project provides a great economic benefit for the 
hospital and will lead to savings that can be used towards other projects within the hospital.   
Methodology 
 In order to implement oral glucose gel as the first line of treatment for hypoglycemic 
newborns, the project will use Lewin’s Theory of Planned Change. According to Shirey (2013), 
Lewin’s Theory of Change includes three stages: unfreezing, moving or transitioning, and 
refreezing.  
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 The first step would be to unfreeze the current protocol by displaying evidence of the 
need for change to all members of the multidisciplinary team. Since all members play a role in 
the implementation of this project, lateral integration will be used to bring together the 
physicians, nurses, pharmacists, and administrative staff to explain the evidence that was found 
with the new intervention. Data will be collected on the newborn breastfeeding rates before the 
new intervention and after the new intervention. This will be used to compare the success of the 
project. Once all stakeholders are on board with the project, the protocol will be rewritten to 
include the new intervention. 
 In the transitioning/moving stage, “super-users” will educate nurses on the administration 
of oral buccal gel for hypoglycemic infants. Pharmacy will add weight-based doses of glucose 
gel in their formulary for dispensing. 
 The refreezing stage will take place after the new protocol has been implemented. The 
goal during this stage will be to ensure that staff is following the new protocol and that the 
results are tracked and shared to promote compliance. By comparing data on the number of 
breastfeeding newborns after the implementation of oral glucose gel, the team will know whether 
they have reached the desired goal of an 80% breastfeeding rate. 
Data Source/ Literature Review 
 The following PICO search was used to find research on the topic:  
P: Newborn infants with hypoglycemia 
I: Oral dextrose gel 
C: Supplemented formula  
O: Breastfeeding Rates 
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 The CINAHL data base was used for the PICO search. An initial search on the subject of 
"oral dextrose gel" only yielded four results, of which three were relevant to my project. When 
the search was narrowed to include “infant hypoglycemia” and "oral dextrose gel for the 
treatment of hypoglycemia", it yielded many more results.  
 In an article by Bennett, Fagan, Chaharbakhshi, Zamfirova, and Flicker (2016), the 
authors developed a new algorithm for the treatment of infant hypoglycemia at Advocate 
Lutheran General Hospital in Park Ridge, IL. Due to the typical treatment of supplementing 
formula and IV dextrose therapy interrupting breastfeeding and maternal-infant bonding, 
Bennett’s et al. (2016) new algorithm called for the administration of 40% oral glucose gel. Data 
collection over a 14-month period showed that the new intervention reduced infant admission 
rates to the NICU for hypoglycemia by 73%.  It also provided breastfeeding exclusivity rates. 
Forty-nine percent of the women with neonates at risk for hypoglycemia who wished to breast-
feed were able to exclusively breastfeed (Bennett et al., 2016).  
 Harding et al. (2016) designed a randomized placebo-centered trial using 40% buccal 
dextrose gel. The aim of the trial was to determine if oral dextrose gel administered for treatment 
of newborn hypoglycemia would reduce admission to the NICU. Infants at risk for 
hypoglycemia, less than one hour old, and of mothers who intended to breastfeed were randomly 
placed in a dextrose gel group or placebo group. The study group received 0.5 ml/kg of dextrose 
gel while the placebo group received 2% hydroxymethylcellulose. Both interventions would be 
given alongside breast milk. Outcomes of the trial are to be evaluated through admission rates to 
the NICU and will be available at a future date (Harding et al., 2016).  
 Harris, Weston, Signal, Chase and Harding (2016) assessed the effects of oral dextrose 
gel on newborn hypoglycemia in a study named “The Sugar Babies Study.” Using a randomized, 
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double-blind placebo-controlled trial, the researchers incorporated newborn infants from 35-42 
weeks gestation, less than 48 hours old, and having one or more risk factors for hypoglycemia. 
The trial was done at a tertiary hospital in New Zealand. Babies were randomly assigned to a 
placebo group or a 40% dextrose gel group receiving 200 mg/kg. Two hundred and thirty-seven 
of the 514 enrolled infants became hypoglycemic and were placed into the randomized groups. 
The results showed that dextrose gel babies had less failed glucose levels after two treatment 
attempts, showing that dextrose gel is a simple, inexpensive, and effective form of management 
for hypoglycemia.  
 Two years later, Harris et al. (2016) released a follow up trial to the Sugar Babies Study. 
According to the authors, the main purpose behind treating infant hypoglycemia is to prevent 
brain injury. Thus, they developed a two-year follow-up trial inviting the same children from the 
Sugar Babies study to participate, assessing the long term effects of dextrose gel compared with 
placebo gel on neurosensory impairment at 2 years of age. Assessments included neurologic 
function, general health, cognitive skills, behavior skills, language skills, motor skills, executive 
function, and vision. The results showed that of the children assessed, 38% of the dextrose gel 
group and 34% of the placebo group had neurosensory impairments. This indicated that dextrose 
gel is a safe treatment option for neonatal hypoglycemia, but neurosensory impairment is not 
decreased.   
 Hegarty et al. (2016) conducted a randomized controlled trial. Babies at risk for 
hypoglycemia, but without indications for NICU admission, were randomized into eight groups 
at two hospitals in New Zealand. There were four placebo groups, and four dextrose gel groups 
consisting of babies receiving dextrose gel at either 200 mg/kg one time at one hour of life, 400 
mg/kg one time at one hour of life, 200 mg/kg for four doses, or 400 mg/kg one time followed by 
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200mg/kg doses for three additional doses. Between August 2013 and November 2014, 416 
infants were placed into randomized groups. The results showed that dextrose gel infants were 
less likely to develop hypoglycemia than placebo infants.  Admission rates to NICU for 
hypoglycemia were less common for infants in the dextrose gel group. Breastfeeding rates were 
similar in both groups. There were low adverse effects noted in either group. The overall 
conclusion was that a single dose of dextrose gel administered at 200 mg/kg reduced the 
incidence of neonatal hypoglycemia.   
 Rawat et al. (2016) studied the effect of dextrose gel therapy with feeds in asymptomatic 
hypoglycemic preterm and term infants. The authors’ aim was to see its effects on reducing IV 
dextrose therapy. They performed a retrospective study before and after the dextrose gel use. 
Infants with blood glucose levels less than 45 mg/dL were given three doses of gel at 200 mg/kg 
in addition to their feeds. If the infants had to be transferred to the NICU, this was considered a 
failure. The results showed that dextrose gel in addition to feeds increased blood sugar in 74% of 
infants compared to 54% in infants who only received feedings. Transfers to the NICU decreased 
from 35/1,000 to 25/1,000.   
 Weston et al. (2016) reviewed the effectiveness of oral dextrose gel in treating newborn 
hypoglycemia and reducing long-term neurosensory impairment. Using various randomized and 
quasi-randomized studies, the investigators compared dextrose gel with placeboes, no treatment, 
or other methods of treatment. Two trials were done with 312 infants. The results showed that no 
evidence exists of a difference between a placebo and dextrose gel for long-term neurosensory 
impairment. Dextrose gel did not make a difference in the reduction of IV dextrose therapy in 
both trials. However, hypoglycemic infants who received dextrose gel therapy were less likely to 
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be separated from their mothers during treatment and had a higher chance of being exclusively 
breastfed after discharge.   
Timeline 
 The project developed due to concerns raised over the unit’s current breastfeeding rates 
between 2015-2016. New evidence was becoming available for the treatment of newborn 
hypoglycemia and it was being adopted successfully by surrounding hospitals in this particular 
community. In November 2016 the planning phase of the PDSA cycle began. An audit was done 
of the monthly breastfeeding rates over 2015 and 2016 to gain a baseline of the unit’s current 
situation. The audit revealed lower rates than the unit’s target range, which was primarily 
because the hospital’s protocol for infant hypoglycemia called for formula feedings. This 
indicated a need for change in the department in order to increase breastfeeding rates. The oral 
dextrose gel intervention was further researched to see how it could benefit the hospital’s 
breastfeeding rates. In December, plans were made to move forward with the process of getting 
it approved. The Nurse Educator and the head of the project, presented to members of the 
healthcare team. Before bringing the project up to other departments, the prospective project was 
presented to the labor and delivery and NICU nursing department directors in January. Once 
accepted by the directors, the proposed project was then presented to other departments, and then 
presented to the neonatologists. The neonatologists approved the idea of the project in February. 
In March of 2017, the proposed project was presented to the pharmacy and approved. 
Pharmacy already had the glucose gel in their dispensing formulary because it is often 
used for adults. However, they needed to gain approval to use the buccal gel for an off-label 
purpose.  
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By mid- April, 2017 the goal was to have IT place the order set into the electronic 
medical record as a PRN order. This way the buccal gel can be signed off and scanned as a 
completed task every time it is administered. The plan is to have the project implemented by 
mid-May, 2017. Six months after implementation, the progress of the project will be checked 
and the intervention reevaluated. The timeline is displayed in Appendix C.   
Expected Results 
 At the end of the six-month implementation phase of the project, it is projected that the 
unit’s monthly breastfeeding rates will increase from the current average of 65%. It will never be 
at 100% because some parents choose not to breastfeed at all. However, a 20% increase is a 
realistic goal for this project. If the breastfeeding rates increase, patient satisfaction scores may 
also be positively affected. Mothers will have increased maternal-child bonding time and greater 
success initiating the breastfeeding process.   
Nursing Relevance 
 Using oral glucose gel as a form of treatment for newborn hypoglycemia and to increase 
breastfeeding rates could potentially have a positive impact on the nursing profession. This could 
allow nurses to provide higher quality of care to newborns during the initial days of their life and 
better abide by the QSEN competencies of patient-centered care, quality improvement, and 
safety.  
 This project improves quality of care because using oral glucose gel at the bedside for 
infants with low blood sugars, allows for increased maternal-infant bonding time, which has had 
beneficial outcomes for mothers and infants. Skin-to-skin time will not be interrupted because 
glucose checks and buccal gel administration can be done while the infant is on the mother. 
Safety at the bedside is supported since bottle -feeding can have aspiration risks if not done 
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properly (Saint Luke’s, 2015).  The entire process of implementing this project also promotes 
dialogue and collaboration amongst multidisciplinary members, creating a stronger team that can 
better serve its patients.  
Summary Report 
 The aim of this CNL project was to increase breastfeeding rates by transitioning from 
supplemental formula feedings to oral glucose gel for the treatment of newborn hypoglycemia. 
With this change, the goal is to increase breastfeeding rates by 20%. The project took place in a 
large community hospital in Southern California, targeting newborn infants on the labor and 
delivery, mother baby, and NICU units.  
The unfreezing, transitioning, and refreezing stages of Lewin’s Theory of Planned 
Change were used throughout the project. The unfreezing stage took place when a 2015-2016 
audit was done of the microsystem’s breastfeeding rates, revealing a 65% breastfeeding rate. A 
fishbone diagram (Appendix A) also identified the causes of the unit’s decreased rates. With the 
help of the data from the hospital’s tracking system, the project’s team concluded that the current 
protocol in place for newborn hypoglycemia needed to be changed to remove supplemental 
formula as the treatment. Through collaboration with the unit’s nurse educator and local 
hospitals in this particular area, the team collected articles revealing evidence-based success with 
the use of oral dextrose gel instead of formula. To resolve the issue, the project’s team will 
change the current policy to oral dextrose gel in conjunction with breastfeeding as the treatment 
for newborn hypoglycemia. This will begin in mid-May, 2017 where super-users will train all 
bedside staff on the weight-based administration of the oral buccal gel.  
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Sustainability relies on five factors, modification of the program, having a champion, fits 
with the organization’s mission/procedures, perceived benefits of the staff/clients, and support 
from stakeholders (Harris, Roussel, & Thomas, 2014). In order to maintain the sustainability of 
this project, the team has incorporates some of these factors into their plan.  As a Baby-Friendly 
hospital, the project aligns well with the baby-friendly guidelines. The goal is that by using oral 
glucose gel on infants with low blood sugars, mothers can continue to breastfeed without having 
to supplement with infant formula. The mission of the organization is to provide the highest 
quality of care to the communities it serves (Hospital X, 2017). Quality of Care is a priority for 
this project and the stakeholders involved with it. Primary stakeholders such as the nursing 
directors, the nurse educator, Pediatricians, and Pharmacy are supportive in the progression of 
the project. This project is also sustainable because it will be standardized. There will be a 
written policy published and readily available on the hospital’s Policies and Procedures site, 
including the changes and a process map to clearly display the steps that need to be taken when 
caring for a hypoglycemic infant.  
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Appendix A 
Root Cause Analysis Fishbone Diagram  
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Appendix B 
Revised Hospital Policy Flow Chart 
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Appendix C 
Timeline 
November 
2016 
December 
2016 
January 
2017 
February 
 2017 
March 
2017 
April  
2017 
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2017 
November 
2017 
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glucose gel 
further 
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 Decision 
made to 
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with the 
project. . 
      
  Project 
presented to 
L&D and 
NICU 
nursing 
directors. 
Approved.  
     
   Project 
presented to 
Neonatologists. 
Approved. 
    
    Project 
presented 
to 
Pharmacy. 
Approved.  
   
     IT placed 
order set 
in EMR 
by April 
15. 
Project to 
go live 
May 15. 
 
       Project 
progress 
checked and 
reevaluated. 
 	
